Global Roundup: Hansa, OSE Nab New Funding, F-Star Links wit

Hansa Biopharma secured $70 million in non-dilutive financing, OSE secured $300 million in funding while CN Bio opened a new contract research facility and more global biopharma news.

Related Keywords

United Kingdom , Portugal , Czech Republic , Germany , Hungary , Netherlands , Israel , Croatia , Slovenia , Italy , Sweden , Bulgaria , Cambridge , Cambridgeshire , Poland , Spain , France , Greece , Romania , Czechia , Israeli , Hansa Biopharma , Cardinor Secretoneurin , Donato Spota , Development Agreement , Us National Cancer Institute , Medigus Ltd , University Of Oxford , Oxford Science Enterprises , Drug Administration , Polyrizon Ltd , Adani Group , Nurexone Biologic Inc , European Medicines Agency , Cardior Pharmaceuticals , Tilray Brands Inc , Novaquest Capital , Financial Officer Donato Spota , Biologics License Application , Cambridge Science , Star Therapeutics , F Star Therapeutics , Sight Robotics , Israel Based Forsight Robotics , Eclipse Ventures , Ribbon Biolabs , Canada Based Xortx Therapeutics , Tilray Medical , Cooperative Research , Cancer Institute , Polar Express ,